Elucidating and targeting the mechanisms encoded in the genome of long-lived individuals to improve healthy ageing

Project description

Genetic factors that determine health in old age

According to the World Health Organization, 1 in 6 people in the world will be aged 60 years or over by 2030. While living longer is certainly desirable, ageing has been linked to many challenges such as serious illnesses. However, there are some individuals who age well and seem to escape or delay age-related diseases. The EU-funded ElucidAge project seeks to shed light on this phenomenon by investigating genetic variants that are unique to long-lived individuals. The project will use cell culture and animal models such as mice to examine if and how the genes containing these variants play an active role in health in advanced age.

Fields of science

• medical and health sciences › basic medicine › neurology › dementia
• medical and health sciences › clinical medicine › cardiology › cardiovascular diseases
• medical and health sciences › clinical medicine › oncology
• natural sciences › biological sciences › genetics › genomes

Programme(s)

• HORIZON.1.1 - European Research Council (ERC) Main Programme

Topic(s)

• ERC-2021-STG - ERC STARTING GRANTS

Call for proposal

ERC-2021-STG

See other projects for this call

Funding Scheme

HORIZON-AG - HORIZON Action Grant Budget-Based

Coordinator

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV

Net EU contribution

€ 1 500 000,00

Address

Hofgartenstrasse 8
80539 Munchen
Germany

Region

Bayern › Oberbayern › München, Kreisfreie Stadt

Activity type

Research Organisations

Links

Other funding

€ 0,00